PATENT CLAIM ANALYSIS

Application Number: 16060146
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["514", "255050"]

Abstract:
The present invention discloses a five-membered heterocyclic amide WNT pathway inhibitor, which belongs to a compound that regulates the activity of a Wnt signaling pathway, and provides a method for preparing such a compound, and the use of such a compound in preparing a medicament that antagonizes the Wnt signaling pathway. The five-membered heterocyclic amide WNT pathway inhibitor provided by the invention has a remarkable anti-tumor activity based on a target-based rational drug design of, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.

Claim (Index 14):
The five-membered heterocyclic amide Wnt pathway inhibitor according to  claim 3 , wherein the aryl group is a phenyl, naphthyl or anthryl group; the heterocyclyl group is a morpholinyl, piperidyl, pyridyl, pyrimidinyl, pyranyl, thienyl, furyl, pyrrolyl, pyrazolyl, imidazolyl or thiazolyl group; and the halogen is selected from one of a group consisting of fluorine, chlorine, bromine and iodine.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.83051
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15699112', '13948038', '13132294', '12263949', '14214185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8037135963776894
- 35 USC 102 Novelty (BERT): 0.5339702037439934
- Combined Prediction Score: 0.7767392571143198
- Mean Citation Score: 331.698596
- Max Citation Score: 350.51352
- Similarity Product: 250.0969409845877

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test